Some drugs may dampen the benefits of exercise, while others amplify them
Live Forever Club - 01-Jan-2024Complex interactions with drugs like Rapamycin, Metformin, and SGLT2 inhibitors
Join the club for FREE to access the whole archive and other member benefits.
Associate Professor at University of Wisconsin-Madison
Dr. Rozalyn Anderson is a faculty member of the Division of Geriatrics and Gerontology and the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine. She is affiliated with the Department of Nutritional Sciences and the Institute on Aging. She serves as Health Officer at the Geriatric Research Education and Clinical Center at the William S. Middleton Memorial Veterans Hospital. Her research focuses on the fundamental biology of aging and what creates the age-associated increase in vulnerability to a spectrum of diseases and disorders including cancer, diabetes, cardiovascular disease, and neurodegeneration.
Dr. Anderson is Director of the Metabolism of Aging program at the UW School of Medicine and Public Health and Associate Director of the Biology of Aging and Age-Related Diseases T32 training program. She is a member of the UW Carbone Cancer Center, the UW Institute for Clinical and Translational Research, the Morgridge Institute for Research, and the Wisconsin Alzheimer’s Disease Research Center. She is Co-Editor in Chief for the Journals of Gerontology Biological Sciences and serves on the editorial board for the journals Geroscience, EBioMedicine, and Nutrition and Healthy Aging.
Visit website: https://www.medicine.wisc.edu/people-search/people/staff/905
See also: University of Wisconsin-Madison - Public Research university
Details last updated 04-Mar-2020
Non-profit dedicated to biomedical aging studies, geroscience and slowing the aging process
06-Sep-2021 to 08-Sep-2021
Jointly organised with the Biochemical Society - researcher disciplines include biochemistry, biology and medicine
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Complex interactions with drugs like Rapamycin, Metformin, and SGLT2 inhibitors
Metabolism remained same throughout the mid-life and starts to decline only at 60 years
May be it's not just one factor but a combination of all the right factors
CALERIE multi-centre trial tested 200 healthy, non-obese adults over 2 years. State-of-the-art m...